{"database": "lobbying", "table": "lobbying_activities", "rows": [[1547370, "e4d5f5ca-3b99-4ae9-a7d7-a611ee263a70", "2T", "SQUIRE PATTON BOGGS", 30906, "RANBAXY INC.", 2014, "second_quarter", "PHA", "S. 214, Preserve Access to Affordable Generics; Implementation of P.L. 111-148, Patient Protection & Affordable Care Act; Prescription Drug User Fee Reauthorization issues; S. 959 Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013.", "HOUSE OF REPRESENTATIVES,SENATE", 120000, null, 0, 1, "2014-07-09T13:49:04.537000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1547370"], "units": {}, "query_ms": 0.36542100133374333, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}